Reviva Pharmaceuticals Inc. announced that it has appointed Brian G. Atwood, Sarvajna Dwivedi and Peder K. Jensen to its Board of Directors. Mr. Atwood brings to Reviva extensive executive and financial experience. He is a co-founder and currently serves as a Managing Director for Versant Ventures, a healthcare-focused venture capital firm.

Prior to launching his career in venture capital, Mr. Atwood was founder, president and CEO of Glycomed. Mr. Atwood also serves on the boards of several pharmaceutical and biotechnology companies. Dr. Dwivedi, an entrepreneur experienced in building and growing companies, brings to Reviva his extensive pharmaceutical development experience.

He co-founded Pearle Therapeutics in 2006. Dr. Jensen brings to Reviva over 24 years of global drug development experience in both pharmaceutical and biotechnology companies and has been responsible for more than forty new drug approvals in the U.S., Europe and Japan during his career. He most recently served as Corporate Senior Vice President and General Manager, R&D for Japan and Asia/Pacific at Schering-Plough Corporation, and earlier he held a number of global senior R&D positions at Schering-Plough, including Senior Vice President of Clinical Research.

Dr. Jensen also serves on the boards of several pharmaceutical and biotechnology companies.